National Bank of Canada’s Novavax NVAX Stock Holding History

National Bank of Canada’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-511	Closed	-$443K	–	3059
2025 Q3	$443K	Sell	511 -252	-33%	-$1.96K	﹤0.01%	1368
2025 Q2	$481K	Buy	+763	New	+$5.05K	﹤0.01%	1417
2025 Q1	–	Sell	-1,653	Closed	-$1.33M	–	3061
2024 Q4	$1.33M	Sell	1,653 -2	-0.1%	-$19	﹤0.01%	1255
2024 Q3	$2.09M	Sell	1,655 -10,356	-86%	-$134K	﹤0.01%	990
2024 Q2	$15.3M	Sell	12,011 -2,631	-18%	-$26.5K	0.02%	454
2024 Q1	$13M	Buy	14,642 +421	+3%	+$1.95K	0.02%	547
2023 Q4	$7.15M	Buy	14,221 +546	+4%	+$3.34K	0.01%	657
2023 Q3	$9.7M	Buy	13,675 +501	+4%	+$4K	0.01%	618
2023 Q2	$9.72M	Sell	13,174 -4,707	-26%	-$37K	0.02%	557
2023 Q1	$12.4M	Buy	17,881 +11,563	+183%	+$106K	0.03%	382
2022 Q4	$6.49M	Buy	+6,318	New	+$111K	0.02%	532

Other funds holding NVAX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

TCMG

TSP Capital Management Group Summit, New Jersey $418M AUM 68.45% 1-Year Est. Return

JAM

Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

National Bank of Canada's NVAX Position: Q2 2026 in Review

National Bank of Canada increased its Novavax (NVAX) stake by 8.3% in Q2 2026, buying an estimated $1.53K and bringing the position to 2,219 shares worth $20.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2236.

National Bank of Canada first reported a position in NVAX in Q4 2021 and has held it in 18 quarters since. The position peaked at $6.26M in Q2 2023. 116 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

National Bank of Canada held 2,219 shares of Novavax worth $20.9K as of Q2 2026.
National Bank of Canada bought 171 Novavax shares in Q2 2026, an estimated $1.53K.
Novavax made up ﹤0.01% of National Bank of Canada's portfolio in Q2 2026, its #2236 holding.
National Bank of Canada first reported a position in Novavax in Q4 2021 and has held it in 18 quarters since.
National Bank of Canada's Novavax position peaked at $6.26M in Q2 2023.
116 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.